This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0509U only for VitaGraft™ Kidney Subsequent from Oncocyte Corporation. This test quantifies donor–derived cell–free DNA (cfDNA) in plasma samples using up to 12 previously identified single–nucleotide polymorphisms (SNPs) to assess the risk of active rejection in kidney transplant patients.
For clinical responsibility, terminology, tips and additional info
start codify free trial.